Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Phase of Trial: Phase IV
Latest Information Update: 21 Jul 2017
At a glance
- Drugs Lamotrigine (Primary)
- Indications Epilepsy
- Focus Pharmacokinetics
- Acronyms EQUIGEN
- 18 Jul 2017 Status changed from active, no longer recruiting to completed.
- 26 Jun 2017 Primary endpoint has been met. (Bioequivalence for generic 1 compared to generic 2), as reported in an article published in the JAMA Neurology.
- 26 Jun 2017 Results published in the JAMA Neurology